These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 31971799)

  • 1. Discovery and Characterization of 2,5-Substituted Benzoic Acid Dual Inhibitors of the Anti-apoptotic Mcl-1 and Bfl-1 Proteins.
    Kump KJ; Miao L; Mady ASA; Ansari NH; Shrestha UK; Yang Y; Pal M; Liao C; Perdih A; Abulwerdi FA; Chinnaswamy K; Meagher JL; Carlson JM; Khanna M; Stuckey JA; Nikolovska-Coleska Z
    J Med Chem; 2020 Mar; 63(5):2489-2510. PubMed ID: 31971799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological evaluation of dual Bcl-2/Mcl-1 inhibitors bearing 2-(1H-indol-4-yl)benzoic acid scaffold.
    Niu Q; Deng H; Zhang Z; Xu Q; Luan S; Huang M; Liu D; Zhao L
    Bioorg Med Chem Lett; 2021 Sep; 47():128215. PubMed ID: 34153472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyquinoline-derived compounds and analoguing of selective Mcl-1 inhibitors using a functional biomarker.
    Richard DJ; Lena R; Bannister T; Blake N; Pierceall WE; Carlson NE; Keller CE; Koenig M; He Y; Minond D; Mishra J; Cameron M; Spicer T; Hodder P; Cardone MH
    Bioorg Med Chem; 2013 Nov; 21(21):6642-9. PubMed ID: 23993674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Small Inhibitory Molecules Targeting the Bfl-1 Anti-Apoptotic Protein That Alleviates Resistance to ABT-737.
    Mathieu AL; Sperandio O; Pottiez V; Balzarin S; Herlédan A; Elkaïm JO; Fogeron ML; Piveteau C; Dassonneville S; Deprez B; Villoutreix BO; Bonnefoy N; Leroux F
    J Biomol Screen; 2014 Aug; 19(7):1035-46. PubMed ID: 24809353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-Phenyl-1H-indole derivatives as a new class of Bcl-2/Mcl-1 dual inhibitors: Design, synthesis, and preliminary biological evaluation.
    Xu G; Liu T; Zhou Y; Yang X; Fang H
    Bioorg Med Chem; 2017 Oct; 25(20):5548-5556. PubMed ID: 28866374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a Covalent Inhibitor That Overcame Resistance to Venetoclax in AML Cells Overexpressing BFL-1.
    Lou J; Zhou Q; Lyu X; Cen X; Liu C; Yan Z; Li Y; Tang H; Liu Q; Ding J; Lu Y; Huang H; Xie H; Zhao Y
    J Med Chem; 2024 Jul; 67(13):10795-10830. PubMed ID: 38913996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in mice.
    Anstee NS; Bilardi RA; Ng AP; Xu Z; Robati M; Vandenberg CJ; Cory S
    Cell Death Differ; 2019 Jul; 26(7):1316-1331. PubMed ID: 30470795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of 3-aryl-rhodanine benzoic acids as anti-apoptotic protein Bcl-2 inhibitors.
    Fu H; Hou X; Wang L; Dun Y; Yang X; Fang H
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5265-9. PubMed ID: 26421995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. hBfl-1/hNOXA Interaction Studies Provide New Insights on the Role of Bfl-1 in Cancer Cell Resistance and for the Design of Novel Anticancer Agents.
    Barile E; Marconi GD; De SK; Baggio C; Gambini L; Salem AF; Kashyap MK; Castro JE; Kipps TJ; Pellecchia M
    ACS Chem Biol; 2017 Feb; 12(2):444-455. PubMed ID: 28026162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and development of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as Bcl-2/Mcl-1 inhibitors.
    Liu R; Liu L; Yang X; Fang H
    Bioorg Chem; 2019 Jul; 88():102938. PubMed ID: 31028992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and structure-activity relationship studies of novel Bcl-2/Mcl-1 dual inhibitors with indole scaffold.
    Zhang Z; Hou L; Bai L; Pei J; Zhao S; Luan S; Liu D; Huang M; Zhao L
    Bioorg Chem; 2022 Aug; 125():105845. PubMed ID: 35512494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of selective Mcl-1 inhibitors via structure-based design and structure-activity relationship analysis.
    He N; Liu P; Wang Z; Guo Z; Yan X; Chen H; Zhang Z
    Biochem Biophys Res Commun; 2019 May; 512(4):921-926. PubMed ID: 30928099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision Targeting of BFL-1/A1 and an ATM Co-dependency in Human Cancer.
    Guerra RM; Bird GH; Harvey EP; Dharia NV; Korshavn KJ; Prew MS; Stegmaier K; Walensky LD
    Cell Rep; 2018 Sep; 24(13):3393-3403.e5. PubMed ID: 30257201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved binding affinities of pyrrolidine derivatives as Mcl-1 inhibitors by modifying amino acid side chains.
    Wan Y; Liu T; Li X; Chen C; Fang H
    Bioorg Med Chem; 2017 Jan; 25(1):138-152. PubMed ID: 27810438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tertiary Structural Motif Sequence Statistics Enable Facile Prediction and Design of Peptides that Bind Anti-apoptotic Bfl-1 and Mcl-1.
    Frappier V; Jenson JM; Zhou J; Grigoryan G; Keating AE
    Structure; 2019 Apr; 27(4):606-617.e5. PubMed ID: 30773399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of A1 to macrophage survival in cooperation with MCL-1 and BCL-X
    Vier J; Häcker G; Kirschnek S
    Cell Death Dis; 2024 Sep; 15(9):677. PubMed ID: 39285161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and development of substituted tyrosine derivatives as Bcl-2/Mcl-1 inhibitors.
    Liu R; Liu L; Liu T; Yang X; Wan Y; Fang H
    Bioorg Med Chem; 2018 Sep; 26(17):4907-4915. PubMed ID: 30170927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based design, synthesis, and evaluation of Bcl-2/Mcl-1 dual inhibitors.
    Zhu J; Wang Z; Guo Z; Zhang X; Song T; Guo Y; Ji T; Zhang Z
    Arch Pharm (Weinheim); 2020 May; 353(5):e2000005. PubMed ID: 32175625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel BH3 mimetic efficiently induces apoptosis in melanoma cells through direct binding to anti-apoptotic Bcl-2 family proteins, including phosphorylated Mcl-1.
    Liu Y; Xie M; Song T; Sheng H; Yu X; Zhang Z
    Pigment Cell Melanoma Res; 2015 Mar; 28(2):161-70. PubMed ID: 25324174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designed BH3 peptides with high affinity and specificity for targeting Mcl-1 in cells.
    Foight GW; Ryan JA; Gullá SV; Letai A; Keating AE
    ACS Chem Biol; 2014 Sep; 9(9):1962-8. PubMed ID: 25052212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.